Combination immunotherapy shows high activity against recurrent Hodgkin lymphoma
A new combination of three drugs that harness the body's immune system is safe and effective, destroying most cancer cells in 95 percent of patients with recurrent Hodgkin lymphoma, according to new results.
from Latest Science News -- ScienceDaily https://ift.tt/2zDC1zu
from Latest Science News -- ScienceDaily https://ift.tt/2zDC1zu
Comments
Post a Comment